Unidade Local de Saude de Loures-Odivelas, EPE (Hospital Beatriz Angelo)

Loures 2674-514

1 studies enrolling now · 2 studies all time

What they study most

Advanced Breast Cancer, Advanced Non Small Cell Lung Cancer, Breast Cancer, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer, PIK3CA Mutation

Studies at this site

• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
• Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation — Running, not enrolling